Literature DB >> 23960629

Down's syndrome and myocardial reperfusion injury.

Susheel Kumar1, Richard Jonas.   

Abstract

Down syndrome is known to be an independent risk factor for mortality after surgical repair of congenital heart anomalies. It is also associated with neurodegenerative disease and accelerated aging. The mechanism of the latter features has been attributed to abnormal handling of oxygen-free radicals as well as mitochondrial dysfunction. These properties also place the child with Down syndrome at a risk of an exaggerated myocardial ischemia/reperfusion injury. A 6 month old child with Down syndrome is reported who suffered from obvious clinical ischemia/reperfusion injury following an uncomplicated repair of complete AV canal. Both intraoperative as well as postoperative echocardiography documented a satisfactory technical repair. After resting the heart on ECMO the child's myocardial function returned to normal. The mechanisms by which patients with Down syndrome are at risk of ischemia/reperfusion injury are reviewed. Future studies should focus on specific approaches for myocardial protection in the child with Down syndrome undergoing cardiac surgery.

Entities:  

Keywords:  Down syndrome; Reperfusion injury; Surgery

Year:  2010        PMID: 23960629      PMCID: PMC3727506          DOI: 10.1016/j.jsha.2010.08.002

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  13 in total

Review 1.  The role of alterations in free radical metabolism in mediating cognitive impairments in Down's syndrome.

Authors:  K L Brugge; S Nichols; D Delis; T Saitoh; D Truaner
Journal:  EXS       Date:  1992

Review 2.  Alzheimer's disease in Down syndrome: neurobiology and risk.

Authors:  Warren B Zigman; Ira T Lott
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2007

3.  Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.

Authors:  Ebrahim Abdul Shukkur; Atsushi Shimohata; Takumi Akagi; Wenxin Yu; Mika Yamaguchi; Miyuki Murayama; Dehua Chui; Tamaki Takeuchi; Kenji Amano; Karthik Harve Subramhanya; Tsutomu Hashikawa; Haruhiko Sago; Charles J Epstein; Akihiko Takashima; Kazuhiro Yamakawa
Journal:  Hum Mol Genet       Date:  2006-08-04       Impact factor: 6.150

4.  Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young Down's syndrome patients.

Authors:  R M Zaldivar-Chiapa; A Y Arce-Mendoza; M De La Rosa-Ramírez; R G Caffesse; J M Solis-Soto
Journal:  J Periodontol       Date:  2005-07       Impact factor: 6.993

5.  Anti-oxidant gene expression imbalance, aging and Down syndrome.

Authors:  Santosh Sinha
Journal:  Life Sci       Date:  2004-12-22       Impact factor: 5.037

6.  Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.

Authors:  Jorge Busciglio; Alejandra Pelsman; Caine Wong; Gustavo Pigino; Menglan Yuan; Hiroshi Mori; Bruce A Yankner
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

7.  Multiple evidence for an early age pro-oxidant state in Down Syndrome patients.

Authors:  Federico V Pallardó; Paolo Degan; Marco d'Ischia; Frank J Kelly; Adriana Zatterale; Rita Calzone; Giuseppe Castello; Rafael Fernandez-Delgado; Christina Dunster; Ana Lloret; Paola Manini; Maria Antonietta Pisanti; Emilia Vuttariello; Giovanni Pagano
Journal:  Biogerontology       Date:  2006-04-13       Impact factor: 4.277

8.  Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects.

Authors:  L Tiano; L Padella; P Carnevali; O Gabrielli; F Bruge; F Principi; G P Littarru
Journal:  Biofactors       Date:  2008       Impact factor: 6.113

9.  Mitochondrial enzyme deficiencies in Down's syndrome.

Authors:  J Prince; S Jia; U Båve; G Annerén; L Oreland
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1994

10.  Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy.

Authors:  Anna Conti; Floriana Fabbrini; Paola D'Agostino; Rosa Negri; Dario Greco; Rita Genesio; Maria D'Armiento; Carlo Olla; Dario Paladini; Mariastella Zannini; Lucio Nitsch
Journal:  BMC Genomics       Date:  2007-08-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.